Alpha Tau Medical (DRTSW) Research & Development (2021 - 2026)
Alpha Tau Medical (DRTSW) posted Research & Development of $11.0 million for Q1 2026, up 14.61% sequentially from $9.6 million in Q4 2025, and up 53.07% YoY from $7.2 million in Q1 2025.
Alpha Tau Medical (DRTSW) Research & Development (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Research & Development for 6 years, with the latest figure at $11.0 million in Q1 2026.
- Quarterly Research & Development rose 53.07% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.9 million (up 29.3% YoY) and the FY2025 annual result came in at $32.1 million, up 18.67% from the prior year.
- Research & Development advanced to $11.0 million in Q1 2026 per DRTSW's latest filing, from $9.6 million in the prior quarter.
- Over five years, Research & Development peaked at $11.0 million in Q1 2026 and troughed at $4.8 million in Q3 2022.
- A 5-year average of $6.9 million and a median of $6.7 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2024: Research & Development surged 139.15% in 2022, then slipped 7.49% in 2024.
- Over 5 years, Research & Development stood at $5.4 million in 2022, then surged by 39.22% to $7.5 million in 2023, then grew by 0.57% to $7.5 million in 2024, then advanced by 27.12% to $9.6 million in 2025, then rose by 14.61% to $11.0 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $11.0 million, $9.6 million, and $8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Alpha Tau Medical | 347.77 Mn | 165.35 Mn | - | 9.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.91 Mn |
| Mar 31, 2026 | 10.98 Mn |
| Dec 31, 2025 | 9.58 Mn |
| Sep 30, 2025 | 8.31 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Mar 31, 2025 | 7.17 Mn |
| Dec 31, 2024 | 7.53 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 6.87 Mn |
| Mar 31, 2024 | 6.45 Mn |
| Dec 31, 2023 | 7.49 Mn |
| Sep 30, 2023 | 6.67 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 6.31 Mn |
| Dec 31, 2022 | 5.38 Mn |
| Sep 30, 2022 | 4.83 Mn |
| Jun 30, 2022 | 5.45 Mn |
| Mar 31, 2022 | 5.24 Mn |
| Dec 31, 2021 | 3.23 Mn |
| Sep 30, 2021 | 3.03 Mn |